Edwards Lifesciences Financials

EWL Stock  EUR 69.90  1.45  2.03%   
Financial data analysis helps to check if markets are presently mispricing Edwards Lifesciences. We were able to interpolate thirty-two available fundamental indicators for Edwards Lifesciences, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Edwards Lifesciences to be traded at €67.1 in 90 days.
  
Understanding current and past Edwards Lifesciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Edwards Lifesciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Edwards Lifesciences' assets may result in an increase in income on the income statement.

Edwards Lifesciences Stock Summary

Edwards Lifesciences competes with GRUPO CARSO, Direct Line, CREDIT AGRICOLE, Chiba Bank, and CARSALESCOM. Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people.
Foreign Associate
  USA
InstrumentGermany Stock View All
ExchangeFrankfurt Exchange
ISINUS28176E1082
Business AddressOne Edwards Way,
SectorHealthcare
IndustryMedical Devices
BenchmarkDow Jones Industrial
Websitewww.edwards.com
Phone949 250 2500
CurrencyEUR - Euro
You should never invest in Edwards Lifesciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Edwards Stock, because this is throwing your money away. Analyzing the key information contained in Edwards Lifesciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Edwards Lifesciences Key Financial Ratios

There are many critical financial ratios that Edwards Lifesciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Edwards Lifesciences reports annually and quarterly.

Edwards Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.
Edwards Lifesciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Edwards Lifesciences is roughly  1.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.

Edwards Lifesciences Systematic Risk

Edwards Lifesciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Edwards Lifesciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Edwards Lifesciences correlated with the market. If Beta is less than 0 Edwards Lifesciences generally moves in the opposite direction as compared to the market. If Edwards Lifesciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Edwards Lifesciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Edwards Lifesciences is generally in the same direction as the market. If Beta > 1 Edwards Lifesciences moves generally in the same direction as, but more than the movement of the benchmark.

Edwards Lifesciences February 25, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Edwards Lifesciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Edwards Lifesciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Edwards Lifesciences based on widely used predictive technical indicators. In general, we focus on analyzing Edwards Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Edwards Lifesciences's daily price indicators and compare them against related drivers.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance